About Icatibant Injection

Why Icatibant Injection?

Icatibant Injection treats all types of acute HAE attacks, including skin (cutaneous), stomach (abdominal), and throat (laryngeal).

Fresenius Kabi’s FDA-approved generic Icatibant Injection offers patients an affordable, fully substitutable, chemically equivalent* option in treating acute attacks of Hereditary angioedema (HAE). Icatibant Injection is indicated for the treatment of acute attacks of HAE in adults 18 years of age and older.

Convenient, on-demand treatment gives you the confidence you need to live freely, knowing you have a medicine you can use at the first signs of HAE symptoms.

Talk to your doctor to see if Icatibant Injection is the right on-demand treatment for you.

Convenient & Easy to Use

Fully Substitutable and Chemically Equivalent*

The package and pre-filled syringe are convenient and easy to use whether you’re at home or on-the-go. Icatibant Injection can be used both in and out of the home—after training by a healthcare professional.

Remember HAE Attacks Are Unpredictable

There is no way to predict with 100% certainty when an attack will occur, where in the body it will occur, or how severe it will be. Even if your attack is a mild one, Icatibant Injection can reduce the length of time the attack lasts.3,11

If your symptoms continue or come back, you may repeat your Icatibant Injection at least six hours apart. Do not use more than 3 doses in 24 hours.11

Why Switch?

References

  • [3] Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update. Allergy. 2022;77(7):1961-1990.
  • [11] Icatibant Injection Prescribing Information. Fresenius Kabi USA, LLC; 2020.

*Fresenius Kabi’s Icatibant Injection is fully substitutable and chemically equivalent to Firazyr®.